We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Theracryf Plc | TCF | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.775 | 08:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.775 | 0.775 | 0.775 | 0.775 | 0.775 |
| Industry Sector |
|---|
| EQUITY INVESTMENT INSTRUMENTS |
| Top Posts |
|---|
Posted at 19/7/2024 08:47 by clocktower Huge internet problems that appears not only to have effected airlines but to have hit a number of MM as there are fewer quotes this morning.I was considerting topping up with TCF this morning, as I feel something positive is going on, in light of the trades recently, but this outage is a problem it seems. Did anyone go to the AGM yesterday by the way and any comments? |
Posted at 10/7/2024 14:23 by clocktower The reason for the change of direction. Good news.All it wants now is a couple of good RNS and it will soon be 2p plus . Someone might have had a sniff of this news a couple of days ago, when that 200k buy occured, |
Posted at 04/6/2024 20:03 by terrydevlin1 Good luck Mark and CT. Whilst the Stalicla deal is still live I can’t see how this can go down much lower. But that deal looks to be on the rocks IMO. The fact TCF no longer mentioned up to $5.5m expected this year in the full results and Stalicla also removed from their website that this would go into phase 2 in 2024, it doesn’t look good. If the deal collapses this share price will be 0.1p and it’s game over. I question where is the money going to come from to bankroll this company? TCF needs between £3m and £4m a year which is enormous sums of money.I’ve been doing alright recently on the virtual dogs at the bookies, I’d rather stick a grand on a virtual dog than this dog of a share. |
Posted at 28/5/2024 17:15 by xxproinvestorxx Tcf FY26E is March 31st 2026. |
Posted at 28/5/2024 17:14 by xxproinvestorxx I didn't hear that in the presentation, however, when writing going concerns they can only report on what happened in the reported period, not after, except for the part that mentions post period. Also look at the research notes issued today, they also say cash into 2026. Say they expect TCF to "close FY26E with a closing cash balance of just under 0.3m" |
Posted at 26/5/2024 12:34 by terrydevlin1 I don’t know how anyone can think the results will be positive at all. Terrible 12 months here. No income, Juvenesense deal collapsed, Stalicla dispute, no new contracts signed, a share placing, money running out, next to no news on SFX-01 progressing. I think TCF may have a decent drug in SFX-01 buy they can’t afford to do any trials and can’t get anyone to trial it for them. Even if TCF get the $5.5m they hoped by the end of the year, where is the next income coming from? Stalicla payments clearly can’t be relied on. The end goal is already written here, another share placement which happens every 2 years is inevitable at some point. The shares will be diluted so much that there is no possibility of shareholders making any money here. There is no hope of TCF ever succeeding now. Don’t waste your time or money here. |
Posted at 10/5/2024 07:12 by terrydevlin1 I agree with your comment Clock Tower. It is incredibly disappointing to have no new deals signed up for SFX-01 since the Stalicla deal. There seems so little news now about SFX-01 in the past 10 months.The sad reality is that TCF cannot afford to do their own trials so they cannot do much to prove the drug is effective and it seems like they cannot get anyone to trial it for them. The Stalicla deal is so huge to TCF that they have no option but to wait for Stalicla to decide what they will do and when they will do it. It is TCF’s only potential income stream and money is running out. It is over a quarter of a year since the dispute was issued and no news at all. It doesn’t feel like there will be any news any time soon either. I feel for all investors who invested as a result of the Stalicla deal announcement in 2022. At that time with £10m in the bank, Juvenesense having a deal with SFX-01 and milestone payments of up to $160m with Stalicla it seemed like this share had great potential. I wish I never had stumbled on that RNS. |
Posted at 13/7/2017 20:40 by rjmahan Glad I sold out of this - lucky escape. I had hoped they would be able to sell down property and repay debt but it obviously hasnt happened like that.Still not entirely convinced its a complete no hoper, debt / NAV was 57% !, telecom assets are high quality - though there is a lot of junk in there too. There was a eur 20m (from memory) payment due in 2017 - part of reason I sold out. Surely can be renegotiated again? Dont entirely trust laxley not to try to pick up TCF on the cheap... Dont think we are anywhere near the bottom yet though.... |
Posted at 31/12/2014 17:51 by rjmahan Sales + Low liquidity. If you read report TCF wont be able to pay out for several years (I estimate 4) unless sold. However after 4 years I recon this can have a 10% yield. |
Posted at 08/1/2013 16:04 by praipus Also surprised we havent seen an "ex-divi" dip. Edit ok guess we wont see one due to the nature of the return. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
